Perioperative haemostasis with full‐length, PEGylated, recombinant factor VIII with extended half‐life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single‐arm phase III trial

First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A

(2017) K. Hampton et al.   HAEMOPHILIA

Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden

(2017) Nathaniel Henry et al.   JOURNAL OF MEDICAL ECONOMICS

Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients

(2016) B. Brand et al.   HAEMOPHILIA

Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A

(2016) E. S. Mullins et al.   HAEMOPHILIA

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

(2015) B. A. Konkle et al.   BLOOD

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

(2013) J. Mahlangu et al.   BLOOD

Modern haemophilia care

(2012) Erik Berntorp et al.   LANCET

Past, present and future of hemophilia: a narrative review

(2012) Massimo Franchini et al.   Orphanet Journal of Rare Diseases

Perioperative clotting factor replacement and infection in total knee arthroplasty

(2011) J. M.-L. WONG et al.   HAEMOPHILIA

The Management of Cardiovascular Diseases in Patients with Hemophilia

(2010) Antonio Coppola et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Co-morbidities and quality of life in elderly persons with haemophilia

(2009) Massimo Franchini et al.   BRITISH JOURNAL OF HAEMATOLOGY

Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy

(2009) E. P. MAUSER-BUNSCHOTEN et al.   HAEMOPHILIA

Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: Efficacy and safety of Advate in previously treated patients

(2008) Amy Shapiro et al.   THROMBOSIS AND HAEMOSTASIS